Ossiam Acquires 20,372 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Ossiam grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 1,193.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 22,079 shares of the biotechnology company's stock after purchasing an additional 20,372 shares during the period. Ossiam's holdings in Axon Enterprise were worth $13,122,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of AXON. Vanguard Group Inc. boosted its holdings in shares of Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock valued at $5,019,886,000 after acquiring an additional 275,959 shares in the last quarter. Geode Capital Management LLC lifted its position in Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock worth $1,095,542,000 after purchasing an additional 65,097 shares during the period. Capital World Investors boosted its stake in Axon Enterprise by 86.4% during the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock valued at $1,079,145,000 after purchasing an additional 841,772 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of Axon Enterprise by 273.8% during the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after purchasing an additional 812,337 shares during the period. Finally, Norges Bank bought a new stake in shares of Axon Enterprise in the 4th quarter worth $482,081,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This represents a 0.33 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Performance

NASDAQ:AXON traded up $16.48 during midday trading on Thursday, reaching $593.38. The stock had a trading volume of 257,803 shares, compared to its average volume of 776,841. The stock has a market capitalization of $46.19 billion, a P/E ratio of 153.33, a PEG ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm's fifty day simple moving average is $549.49 and its 200-day simple moving average is $568.33.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price objective for the company. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. The Goldman Sachs Group increased their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research report on Monday, January 27th. Finally, JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $626.45.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.